Innovation of the process of production of veterinary vaccines against leptospirosis and disease (Q9935): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claim: summary (P836): The purpose of the project is to innovate the process of producing and cultivating vaccines against leptospirosis and borreliosis based on the multiplication of spirochet fermentation culture in an industrial bioreactor. The process of innovation will be realised through the introduction of new technology for producing antigens. Innovation covers a wide range of products (e.g.: Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofl B, Biocan...)
(‎Created claim: summary (P836): The subject of the project is innovation of the process of production and cultivation of leptospirosis and borrelia vaccines based on the enhancement of spirochetes by fermentation in an industrial bioreactor. The innovation of the process will be implemented through the introduction of a new antigen production technology. Innovation concerns a wide range of products (e.g. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Bor...)
Property / summary
 
The subject of the project is innovation of the process of production and cultivation of leptospirosis and borrelia vaccines based on the enhancement of spirochetes by fermentation in an industrial bioreactor. The innovation of the process will be implemented through the introduction of a new antigen production technology. Innovation concerns a wide range of products (e.g. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Borrelym). The project will acquire technology for a new production method, namely bioreactors, formulation boiler and ultrafilter. a. (English)
Property / summary: The subject of the project is innovation of the process of production and cultivation of leptospirosis and borrelia vaccines based on the enhancement of spirochetes by fermentation in an industrial bioreactor. The innovation of the process will be implemented through the introduction of a new antigen production technology. Innovation concerns a wide range of products (e.g. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Borrelym). The project will acquire technology for a new production method, namely bioreactors, formulation boiler and ultrafilter. a. (English) / rank
 
Normal rank
Property / summary: The subject of the project is innovation of the process of production and cultivation of leptospirosis and borrelia vaccines based on the enhancement of spirochetes by fermentation in an industrial bioreactor. The innovation of the process will be implemented through the introduction of a new antigen production technology. Innovation concerns a wide range of products (e.g. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Borrelym). The project will acquire technology for a new production method, namely bioreactors, formulation boiler and ultrafilter. a. (English) / qualifier
 
point in time: 22 October 2020
Timestamp+2020-10-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 14:56, 22 October 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Innovation of the process of production of veterinary vaccines against leptospirosis and disease
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    7,500,000.0 Czech koruna
    0 references
    300,000.0 Euro
    10 January 2020
    0 references
    30,000,000.0 Czech koruna
    0 references
    1,200,000.0 Euro
    10 January 2020
    0 references
    25 percent
    0 references
    19 November 2015
    0 references
    23 August 2018
    0 references
    1 October 2018
    0 references
    Bioveta, a.s.
    0 references
    0 references

    49°18'9.65"N, 17°4'54.52"E
    0 references

    49°17'53.88"N, 17°6'21.31"E
    0 references
    68323
    0 references
    Předmětem projektu je inovace procesu výroby a kultivace vakcín proti leptospiróze a borelióze založená na pomnožení spirochet fermentační kultivací v průmyslovém bioreaktoru. Inovace procesu bude realizována formou zavedení nové technologie výroby antigenů. Inovace se týká celé řady přípravků (např. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Borrelym). V rámci projektu bude pořízena technologie pro nový způsob výroby, a to bioreaktory, formulační kotel a ultrafiltr. a. (Czech)
    0 references
    The subject of the project is innovation of the process of production and cultivation of leptospirosis and borrelia vaccines based on the enhancement of spirochetes by fermentation in an industrial bioreactor. The innovation of the process will be implemented through the introduction of a new antigen production technology. Innovation concerns a wide range of products (e.g. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Borrelym). The project will acquire technology for a new production method, namely bioreactors, formulation boiler and ultrafilter. a. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/15_014/0004382
    0 references